Does SARILUMAB Cause Upper respiratory tract infection? 195 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 195 reports of Upper respiratory tract infection have been filed in association with SARILUMAB (KEVZARA). This represents 0.9% of all adverse event reports for SARILUMAB.
195
Reports of Upper respiratory tract infection with SARILUMAB
0.9%
of all SARILUMAB reports
93
Deaths
105
Hospitalizations
How Dangerous Is Upper respiratory tract infection From SARILUMAB?
Of the 195 reports, 93 (47.7%) resulted in death, 105 (53.8%) required hospitalization, and 89 (45.6%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for SARILUMAB.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which SARILUMAB Alternatives Have Lower Upper respiratory tract infection Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE